The legal action centers on allegations that Hims & Hers misled shareholders between August 4, 2025, and July 29, 2026. According to the complaint, the company failed to disclose that it shared sensitive consumer health data with third-party advertising platforms. Furthermore, the firm allegedly charged users for prescriptions immediately after intake forms were submitted, contradicting claims that patients would first consult with medical providers to determine appropriate treatments.
These practices reportedly invited significant regulatory scrutiny and potential financial penalties for the company. The lawsuit contends that because these operational risks were omitted, the company’s public statements regarding its business prospects lacked a reasonable basis. Shareholders who purchased stock during the specified period may contact the Law Offices of Frank R. Cruz to review their legal options, though participation in the class is not mandatory for those who choose to remain absent members.
Comments (0)
No comments yet. Be the first!